Miniaturized biological systems capable of mimicking complex organ architecture are transforming regenerative medicine. Organoids and lab-grown organs offer powerful platforms for modeling disease, studying development, and exploring therapeutic interventions without relying on animal models. Derived from stem cells and grown in three-dimensional culture systems, organoids self-organize into structures resembling the functional units of organs like the liver, intestine, brain, or kidneys. Coupled with bioreactors and advanced scaffolds, lab-grown organs are progressing toward clinical relevance, especially in transplantation and toxicity testing. Organoids and lab-grown organs bridge developmental biology with engineering, opening new frontiers for personalized treatment, functional organ replacement, and ethical drug discovery that mirrors in vivo responses with remarkable fidelity.
Title : The era of artificial intelligence (AI) and its use in regenerative medicine
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : The role of gingival fibroblasts in periodontal diseases and regeneration
Katarzyna Gawron, Medical University of Silesia in Katowice, Poland
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Role of textile materials in tissue engineering and regenerative medicine
Gokarneshan Narayanan, SSM College of Engineering (Formerly), India
Title : Induction of neo angiogenesis: A way forward for reversing necrosis in complex wounds in orthopaedic practice
Sandeep Shrivastava, Datta Meghe Institute of Medical Sciences, India
Title : Silk-derived sericin at the interface of atopic dermatitis and wound healing: Modulation of inflammation and epidermal repair
Marek Konop, Medical University of Warsaw, Poland